lactic acid and 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one

lactic acid has been researched along with 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Fang, J; Guo, Y; Li, Q; Liu, H; Tong, H; Wang, S; Xie, T; Xu, K; Xue, W; Yi, L; Zhang, J; Zhang, W; Zhou, B	1

Other Studies

1 other study(ies) available for lactic acid and 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one

Article	Year
Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI. Theranostics, 2020, Volume: 10, Issue:16 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Male; Mice; Multiparametric Magnetic Resonance Imaging; Neovascularization, Pathologic; Phosphofructokinase-2; Pyridines; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2020

Article

Year

Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.

Theranostics, 2020, Volume: 10, Issue:16

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Male; Mice; Multiparametric Magnetic Resonance Imaging; Neovascularization, Pathologic; Phosphofructokinase-2; Pyridines; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2020